FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W144188068> ?p ?o ?g. }

• W144188068 endingPage "2700" @default.
• W144188068 startingPage "2689" @default.
• W144188068 abstract "Abstract We report the results of intravenous anti-D (WinRho, WinRho SD) therapy in 261 non-splenectomized patients treated at the New York Hospital-Cornell Medical Center over the period from 1987 to 1994. Children (n = 124) and adult patients (n = 137) with classic immune thrombocytopenic purpura (ITP; n = 156) or human immunodeficiency virus (HIV) related thrombocytopenia (n = 105) and acute (n = 75) or chronic (n = 186) disease at the time of the initial anti-D treatment were studied. In addition, 11 previously splenectomized patients were treated as a separate group. Our objectives were to evaluate the following. (1) Efficacy of anti-D: The response after the initial infusion was analyzed according to clinical parameters, such as patient's age, HIV status, gender, disease duration, pretreatment platelet count, and hemoglobin value, as well as treatment-related factors, including the dose of anti-D, the solvent detergent treatment of the preparation, and the type of administration. (2) Use of anti-D as maintenance therapy: The duration of response after the initial infusion and the results of subsequent treatments were evaluated. (3) Safety/toxicity of anti-D: Postinfusion reactions and hemoglobin decrease after treatment were studied. Anti-D is a safe treatment providing a hemostatic platelet increase in greater than 70% of the Rh+ non-splenectomized patients. The group with the best results is HIV− children, but all patient groups respond and the effect lasts more than 21 days in 50% of the responders. Duration of response is not influenced by HIV status; furthermore, HIV+ patients show no adverse effects on hemoglobin decrease or HIV disease progression. Patients with chronic ITP after splenectomy have minimal or no response to intravenous anti-D." @default.
• W144188068 created "2016-06-24" @default.
• W144188068 creator A5015607070 @default.
• W144188068 creator A5030658031 @default.
• W144188068 creator A5045734746 @default.
• W144188068 creator A5049612498 @default.
• W144188068 creator A5052667544 @default.
• W144188068 creator A5062688748 @default.
• W144188068 creator A5085595407 @default.
• W144188068 date "1997-04-15" @default.
• W144188068 modified "2023-10-18" @default.
• W144188068 title "Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 Patients" @default.
• W144188068 cites W1509737581 @default.
• W144188068 cites W1971957984 @default.
• W144188068 cites W1979820418 @default.
• W144188068 cites W1985624039 @default.
• W144188068 cites W1989611904 @default.
• W144188068 cites W1999172422 @default.
• W144188068 cites W2014048042 @default.
• W144188068 cites W2016592404 @default.
• W144188068 cites W2042996000 @default.
• W144188068 cites W2044506453 @default.
• W144188068 cites W2045279084 @default.
• W144188068 cites W2045321764 @default.
• W144188068 cites W2045403351 @default.
• W144188068 cites W2048259741 @default.
• W144188068 cites W2054145877 @default.
• W144188068 cites W2055687757 @default.
• W144188068 cites W2057481372 @default.
• W144188068 cites W2064063888 @default.
• W144188068 cites W2066270367 @default.
• W144188068 cites W2070705992 @default.
• W144188068 cites W2070883424 @default.
• W144188068 cites W2093500457 @default.
• W144188068 cites W2093563717 @default.
• W144188068 cites W2113669085 @default.
• W144188068 cites W2163543567 @default.
• W144188068 cites W2168788039 @default.
• W144188068 cites W2195796028 @default.
• W144188068 cites W2266815920 @default.
• W144188068 cites W2341400992 @default.
• W144188068 cites W2411509899 @default.
• W144188068 cites W2411809793 @default.
• W144188068 cites W2432059888 @default.
• W144188068 cites W2434593583 @default.
• W144188068 cites W2461602353 @default.
• W144188068 cites W341378017 @default.
• W144188068 cites W39129397 @default.
• W144188068 cites W4232025330 @default.
• W144188068 cites W4240405337 @default.
• W144188068 cites W4241272327 @default.
• W144188068 cites W4247653134 @default.
• W144188068 doi "https://doi.org/10.1182/blood.v89.8.2689" @default.
• W144188068 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9108386" @default.
• W144188068 hasPublicationYear "1997" @default.
• W144188068 type Work @default.
• W144188068 sameAs 144188068 @default.
• W144188068 citedByCount "303" @default.
• W144188068 countsByYear W1441880682012 @default.
• W144188068 countsByYear W1441880682013 @default.
• W144188068 countsByYear W1441880682014 @default.
• W144188068 countsByYear W1441880682015 @default.
• W144188068 countsByYear W1441880682016 @default.
• W144188068 countsByYear W1441880682017 @default.
• W144188068 countsByYear W1441880682018 @default.
• W144188068 countsByYear W1441880682019 @default.
• W144188068 countsByYear W1441880682020 @default.
• W144188068 countsByYear W1441880682021 @default.
• W144188068 countsByYear W1441880682022 @default.
• W144188068 countsByYear W1441880682023 @default.
• W144188068 crossrefType "journal-article" @default.
• W144188068 hasAuthorship W144188068A5015607070 @default.
• W144188068 hasAuthorship W144188068A5030658031 @default.
• W144188068 hasAuthorship W144188068A5045734746 @default.
• W144188068 hasAuthorship W144188068A5049612498 @default.
• W144188068 hasAuthorship W144188068A5052667544 @default.
• W144188068 hasAuthorship W144188068A5062688748 @default.
• W144188068 hasAuthorship W144188068A5085595407 @default.
• W144188068 hasBestOaLocation W1441880681 @default.
• W144188068 hasConcept C126322002 @default.
• W144188068 hasConcept C203014093 @default.
• W144188068 hasConcept C2776309230 @default.
• W144188068 hasConcept C2778917026 @default.
• W144188068 hasConcept C2779771385 @default.
• W144188068 hasConcept C2780931953 @default.
• W144188068 hasConcept C29730261 @default.
• W144188068 hasConcept C71924100 @default.
• W144188068 hasConcept C8891405 @default.
• W144188068 hasConcept C89560881 @default.
• W144188068 hasConcept C90924648 @default.
• W144188068 hasConceptScore W144188068C126322002 @default.
• W144188068 hasConceptScore W144188068C203014093 @default.
• W144188068 hasConceptScore W144188068C2776309230 @default.
• W144188068 hasConceptScore W144188068C2778917026 @default.
• W144188068 hasConceptScore W144188068C2779771385 @default.
• W144188068 hasConceptScore W144188068C2780931953 @default.
• W144188068 hasConceptScore W144188068C29730261 @default.
• W144188068 hasConceptScore W144188068C71924100 @default.

• next